Search research articles
Contact Us
Filters
Showing results (21-30 of 123) with videos related to
Page
of 13
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 31, 2013
Patient-reported outcomes in clinical trials of CKD-related therapies: report of a symposium sponsored by the national kidney foundation and the U.S. Food and Drug Administration
Ronald D Perrone, Stephen Joel Coons, Kerri Cavanaugh, et al.
Kidney360
|
November 21, 2023
Comparing Effects of Tolvaptan and Instruction to Increase Water Consumption in ADPKD: Post Hoc Analysis of TEMPO 3:4
Joga Gobburu, Vijay Ivaturi, Xiaofeng Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 8, 2023
Development of a Patient-Reported Outcomes Tool to Assess Pain and Discomfort in Autosomal Dominant Polycystic Kidney Disease
Dorothee Oberdhan, Jason C Cole, Mark J Atkinson, et al.
Biomaterials
|
September 4, 2012
The regulation of cystogenesis in a tissue engineered kidney disease system by abnormal matrix interactions
Balajikarthick Subramanian, Wei-Che Ko, Vikas Yadav, et al.
Kidney International Reports
|
June 11, 2020
A Randomized Trial of Modified-Release Versus Immediate-Release Tolvaptan in ADPKD
Ronald D Perrone, Arlene B Chapman, Dorothee Oberdhan, et al.
Kidney International Reports
|
June 11, 2020
The NOCTURNE Randomized Trial Comparing 2 Tolvaptan Formulations
Ronald D Perrone, Arlene B Chapman, Dorothee Oberdhan, et al.
Kidney360
|
November 19, 2024
Mission and Future Plans for the Autosomal Dominant Polycystic Kidney Disease Centers of Excellence Program
Elise Hoover, Heidi Cambareri, Arlene B Chapman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 3, 2019
Addressing the Need for Clinical Trial End Points in Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC)
Kimberly A Smith, Aliza M Thompson, David A Baron, et al.
American Journal of Nephrology
|
May 21, 2018
A Randomized Clinical Trial of Metformin to Treat Autosomal Dominant Polycystic Kidney Disease
Stephen L Seliger, Kaleab Z Abebe, Kenneth R Hallows, et al.
Kidney International Reports
|
August 13, 2021
Tolvaptan in ADPKD Patients With Very Low Kidney Function
Vicente E Torres, Ron T Gansevoort, Ronald D Perrone, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 123) with videos related to
Sort By:
Page
of 13
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 31, 2013
Patient-reported outcomes in clinical trials of CKD-related therapies: report of a symposium sponsored by the national kidney foundation and the U.S. Food and Drug Administration
Ronald D Perrone, Stephen Joel Coons, Kerri Cavanaugh, et al.
Kidney360
|
November 21, 2023
Comparing Effects of Tolvaptan and Instruction to Increase Water Consumption in ADPKD: Post Hoc Analysis of TEMPO 3:4
Joga Gobburu, Vijay Ivaturi, Xiaofeng Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 8, 2023
Development of a Patient-Reported Outcomes Tool to Assess Pain and Discomfort in Autosomal Dominant Polycystic Kidney Disease
Dorothee Oberdhan, Jason C Cole, Mark J Atkinson, et al.
Biomaterials
|
September 4, 2012
The regulation of cystogenesis in a tissue engineered kidney disease system by abnormal matrix interactions
Balajikarthick Subramanian, Wei-Che Ko, Vikas Yadav, et al.
Kidney International Reports
|
June 11, 2020
A Randomized Trial of Modified-Release Versus Immediate-Release Tolvaptan in ADPKD
Ronald D Perrone, Arlene B Chapman, Dorothee Oberdhan, et al.
Kidney International Reports
|
June 11, 2020
The NOCTURNE Randomized Trial Comparing 2 Tolvaptan Formulations
Ronald D Perrone, Arlene B Chapman, Dorothee Oberdhan, et al.
Kidney360
|
November 19, 2024
Mission and Future Plans for the Autosomal Dominant Polycystic Kidney Disease Centers of Excellence Program
Elise Hoover, Heidi Cambareri, Arlene B Chapman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 3, 2019
Addressing the Need for Clinical Trial End Points in Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC)
Kimberly A Smith, Aliza M Thompson, David A Baron, et al.
American Journal of Nephrology
|
May 21, 2018
A Randomized Clinical Trial of Metformin to Treat Autosomal Dominant Polycystic Kidney Disease
Stephen L Seliger, Kaleab Z Abebe, Kenneth R Hallows, et al.
Kidney International Reports
|
August 13, 2021
Tolvaptan in ADPKD Patients With Very Low Kidney Function
Vicente E Torres, Ron T Gansevoort, Ronald D Perrone, et al.
Page
of 13